Survival in metastatic breast cancer in the ESME study and the ATRESS effect
- PMID: 33023786
- DOI: 10.1016/j.ejca.2020.08.032
Survival in metastatic breast cancer in the ESME study and the ATRESS effect
Keywords: Adjuvant therapy; Adjuvant therapy–related shortening of survival (ATRESS); Breast cancer; Postrelapse survival.
Conflict of interest statement
Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment in
-
A response letter to comments on "Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016".Eur J Cancer. 2020 Nov;140:165-166. doi: 10.1016/j.ejca.2020.09.005. Epub 2020 Oct 3. Eur J Cancer. 2020. PMID: 33020000 No abstract available.
Comment on
-
Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.Eur J Cancer. 2020 Apr;129:60-70. doi: 10.1016/j.ejca.2020.01.016. Epub 2020 Mar 2. Eur J Cancer. 2020. PMID: 32135312
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
